The Prevalence of Sarcopenic Obesity in Postmenopausal Women with a History of Breast Cancer Depending on Adopted Methodology – A Case–Control Study

References

• Antoun S, Baracos VE, Birdsell L, Escudier B, Sawyer MB. Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma. Ann Oncol. 2010;21(8):1594–1598. doi:10.1093/annonc/mdp605
   PubMed Web of Science ®Google Scholar
• Argolo DF, Hudis CA, Iyengar NM. The impact of obesity on breast cancer. Curr Oncol Rep. 2018;20(6):47. doi:10.1007/s11912-018-0688-8
   PubMed Web of Science ®Google Scholar
• Awad S, Tan BH, Cui H, et al. Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. Clin Nutr. 2012;31(1):74–77. doi:10.1016/j.clnu.2011.08.008
   PubMed Web of Science ®Google Scholar
• Balentine CJ, Enriquez J, Fisher W, et al. Intra-abdominal fat predicts survival in pancreatic cancer. J Gastrointest Surg. 2010;14(11):1832–1837. doi:10.1007/s11605-010-1297-5
   Web of Science ®Google Scholar
• Bandera EV, John EM. Obesity, body composition, and breast cancer: an evolving science. JAMA Oncol. 2018;4(6):804–805. doi:10.1001/jamaoncol.2018.0125
   PubMed Web of Science ®Google Scholar
• Baracos VE, Arribas L. Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy. Ann Oncol. 2018;29(2):ii1–ii9. doi:10.1093/annonc/mdx810
   Web of Science ®Google Scholar
• Baumgartner RN. Body composition in healthy aging. Ann N Y Acad Sci. 2000;904(1):437–448. doi:10.1111/j.1749-6632.2000.tb06498.x
   PubMedGoogle Scholar
• Carneiro IP, Mazurak VC, Prado CM. Clinical implications of sarcopenic obesity in cancer. Curr Oncol Rep. 2016;18(10):62. doi:10.1007/s11912-016-0546-5
   PubMed Web of Science ®Google Scholar
• Cecchini S, Cavazzini E, Marchesi F, Sarli L, Roncoroni L. Computed tomography volumetric fat parameters versus body mass index for predicting short-term outcomes of colon surgery. World J Surg. 2011;35(2):415–423. doi:10.1007/s00268-010-0888-3
   PubMed Web of Science ®Google Scholar
• Cespedes Feliciano EM, Kroenke CH, Caan BJ. The obesity paradox in cancer: how important is muscle? Annu Rev Nutr. 2018;38(1):357–379. doi:10.1146/annurev-nutr-082117-051723
   Web of Science ®Google Scholar
• Chan D, Vieira A, Aune D, et al. Body mass index and survival in women with breast cancer: systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol. 2014;25(10):1901–1914. doi:10.1093/annonc/mdu042
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing. 2010;39(4):412–423. doi:10.1093/ageing/afq034
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Writing group for the European working group on sarcopenia in older people 2 (EWGSOP2), and the extended group for EWGSOP2; sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. doi:10.1093/ageing/afy169
   PubMed Web of Science ®Google Scholar
• Cushen SJ, Power DG, Murphy KP, et al. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate- resistant prostate cancer treated with docetaxel. Clin Nutr. 2016;13:39–45.
   Google Scholar
• Del Fabbro E, Parsons H, Warneke CL, et al. The relationship between body composition and response to neoadjuvant chemotherapy in women with operable breast cancer. Oncologist. 2012;17(10):1240–1245. doi:10.1634/theoncologist.2012-0169
   PubMed Web of Science ®Google Scholar
• Deluche E, Leobon S, Desport JC, et al. Impact of body composition on outcome in patients with early breast cancer. Support Care Cancer. 2018;26(3):861–868. doi:10.1007/s00520-017-3902-6
   PubMed Web of Science ®Google Scholar
• Demark-Wahnefried W, Jacobs Kenyon A, Eberle P, Skye A, Kraus WE. Preventing sarcopenic obesity among breast cancer patients who receive adjuvant chemotherapy: results of a feasibility study. Clin Exerc Physiol. 2002;4(1):44–49.
   Google Scholar
• Demark-Wahnefried W, Peterson BL, Winer EP, et al. Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol. 2001;19(9):2381–2389. doi:10.1200/JCO.2001.19.9.2381
   PubMed Web of Science ®Google Scholar
• Lochs H, Allison SP, Meier R, et al. ESPEN guidelines. Clin Nutr. 2004;23(5i6):1226–43, 1430–53.
   Google Scholar
• Fearon KC, Arends J, Baracos V. Understanding the mechanisms and treatment options in cancer cachexia. Nat Rev Clin Oncol. 2013;10(2):90–99. doi:10.1038/nrclinonc.2012.209
   PubMed Web of Science ®Google Scholar
• Fielding R, Kirn D, Koochek A, et al. PT02.5: impact of a structured physical activity program and nutritional supplementa- tion on regional body composition: results from the vitality, independence, and vigor in the elderly 2 study (VIVE2). Clin Nutr. 2016;35:S25. doi:10.1016/S0261-5614(16)30294-1
   Google Scholar
• Hamer M, O’Donovan G. Sarcopenic obesity, weight loss, and mortality: the english longitudinal study of ageing. Am J Clin Nutr. 2017;106(1):125–129. doi:10.3945/ajcn.117.152488
   PubMed Web of Science ®Google Scholar
• Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50(5):889–896. doi:10.1046/j.1532-5415.2002.50216.x
   PubMed Web of Science ®Google Scholar
• Krzymińska-Siemaszko R, Czepulis N, Rzepnicka A. Ocena ryzyka sarkopenii u starszych kobiet. Now Lekarskie. 2013;82(1):19–24.
   Google Scholar
• Krzymińska-Siemaszko R. Wieczorkowska-Tobis K: Ocena sarkopenii u osób starszych – przyczynek do metodologii. Now Lekarskie. 2012;81/1:16–20.
   Google Scholar
• Kyrgiou M, Kalliala I, Markozannes G, et al. Adiposity and cancer at major anatomical sites: umbrella review of the literature. BMJ. 2017;28:356. doi:10.1136/bmj.j477
   Web of Science ®Google Scholar
• Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE. Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer. 2012;107(6):931–936. doi:10.1038/bjc.2012.350
   PubMed Web of Science ®Google Scholar
• Lieffers JR, Mourtzakis M, Hall KD, et al. A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands. Am J Clin Nutr. 2009;89(4):1173–1179. doi:10.3945/ajcn.2008.27273
   PubMed Web of Science ®Google Scholar
• Ligibel JA, Alfano CM, Courneya KS, et al. American society of clinical oncology position statement on obesity and cancer. J Clin Oncol. 2014;32(31):3568–3574. doi:10.1200/JCO.2014.58.4680
   PubMed Web of Science ®Google Scholar
• Milewska M, Sińska B, Sych D, Kucharska A. Częstość występowania otyłości sarkopenicznej w grupie kobiet w wieku pomenopauzalnym w zależności od przyjętej metodologii – badanie wstępne. Pol Merkur Lekarski. 2015;XXXVIII/226:206–210.
   Google Scholar
• Moon HG, Ju YT, Jeong CY, et al. Visceral obesity may affect oncologic outcome in patients with colorectal cancer. Ann Surg Oncol. 2008;15(7):1918–1922. doi:10.1245/s10434-008-9891-4
   PubMed Web of Science ®Google Scholar
• Nagrani R, Mhatre S, Rajaraman P, et al. Central obesity increases risk of breast cancer irrespective of menopausal and hormonal receptor status in women of South Asian ethnicity. Eur J Cancer. 2016;66:153–161. doi:10.1016/j.ejca.2016.07.022
   PubMed Web of Science ®Google Scholar
• Playdon MC, Bracken MB, Sanft TB, Ligibel JA, Harrigan M, Irwin ML. Weight gain after breast cancer diagnosis and all-cause mortality: systematic review and meta-analysis. J Natl Cancer Inst. 2015;107(12):djv275. doi:10.1093/jnci/djv275
   Google Scholar
• Prado CM, Baracos VE, McCargar LJ, et al. Body composition as an independent determinant of 5-fluorouracil-based chemo- therapy toxicity. Clin Cancer Res. 2017;13(11):3264–3268. doi:10.1158/1078-0432.CCR-06-3067
   Web of Science ®Google Scholar
• Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7):629–635. doi:10.1016/S1470-2045(08)70153-0
   PubMed Web of Science ®Google Scholar
• Prado CM, Sawyer MB, Ghosh S, et al. Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential? Am J Clin Nutr. 2013;98(4):1012–1019. doi:10.3945/ajcn.113.060228
   PubMed Web of Science ®Google Scholar
• Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Million women study collaboration. Cancer incidence and mortality in relation to body mass index in the million women study: cohort study. BMJ. 2007;335(7630):1134. doi:10.1136/bmj.39367.495995.AE
   PubMed Web of Science ®Google Scholar
• Rier HN, Jager A, Sleijfer S, et al. Low muscle attenuation is a prognostic factor for survival in metastatic breast cancer patients treated with first line palliative chemotherapy. Breast. 2017;31:9–15. doi:10.1016/j.breast.2016.10.014
   PubMed Web of Science ®Google Scholar
• Sandini M, Bernasconi DP, Fior D, et al. A high visceral adipose tissue to skeletal muscle ratio as a determinant of major complications after pancreatoduodenectomy for cancer. Nutrition. 2016;32(11–12):1231–1237. doi:10.1016/j.nut.2016.04.002
   PubMed Web of Science ®Google Scholar
• Schutz Y, Kyle UU, Pichard C. Fat-free mass index and fat mass index percentiles in Caucasians aged 18–98 y. Int J Obes Relat Metab Disord. 2002;26(7):953–960. doi:10.1038/sj.ijo.0802037
   PubMed Web of Science ®Google Scholar
• Stenholm S, Harris TB, Rantanen T, Visser M, Kritchevsky SB, Ferrucci L. Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care. 2008;11(6):693–700. doi:10.1097/MCO.0b013e328312c37d
   PubMed Web of Science ®Google Scholar
• Tan BH, Birdsell LA, Martin L, Baracos VE, Fearon KC. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res. 2009;15(22):6973–6979. doi:10.1158/1078-0432.CCR-09-1525
   PubMed Web of Science ®Google Scholar
• Tichet J, Vol S, Goxe D, Salle A, Berrut G, Ritz P. Prevalence of sarcopenia in the French senior population. J Nutr Health Aging. 2008;12(3):202–206. doi:10.1007/BF02982621
   Web of Science ®Google Scholar
• Villaseñor A, Ballard-Barbash R, Baumgartner K, et al. Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL study. J Cancer Surviv. 2012;6(4):398–406. doi:10.1007/s11764-012-0234-x
   Web of Science ®Google Scholar
• Yip C, Goh V, Davies A, et al. Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer. Eur Radiol. 2014;24(5):998–1005. doi:10.1007/s00330-014-3110-4
   PubMed Web of Science ®Google Scholar
• Yung RL, Ligibel JA. Obesity and breast cancer: risk, outcomes, and future considerations. Clin Adv Hematol Oncol. 2016;14(10):790–797.
   Google Scholar
• Zamboni M, Mazzali G, Fantin F, Rossi A, Di Francesco V. Sarcopenic obesity: a new category of obesity in the elderly. Nutr Metab Cardiovasc Dis. 2008;18(5):388–395. doi:10.1016/j.numecd.2007.10.002
   PubMed Web of Science ®Google Scholar
• Pecorelli N, Carrara G, De Cobelli F, et al. Effect of sarcopenia and vis- ceral obesity on mortality and pancreatic fistula following pancreatic cancer surgery. Br J Surg. 2016;103(4):434–442. doi:10.1002/bjs.10063
   PubMed Web of Science ®Google Scholar